DATE: December 1, 2016
TIME:  8:00 AM PT, 11:00 AM ET

Preclinical imaging enables the measurement and assessment of biological processes in vivo utilizing technologies such as bioluminescence, fluorescence and positron emission tomography (PET) platforms to assay cells, tissues, and living organisms. PerkinElmer’s suite of optical and PET scanners set the industry standard for sensitivity, quantitative accuracy, and data reproducibility. This enables premier research institutions like UCLA the opportunity to advance preclinical and translational science while fostering collaboration among imaging laboratories both internally and externally. In this institutional highlight webinar series, we are excited to share insight on how a successful imaging program at UCLA has been instrumental in generating novel models of disease and conducting cutting edge research.
 
You will hear from Dr. Jason Lee, Director of the Preclinical Imaging Technology Center, Crump Institute for Molecular Imaging, who will highlight imaging technologies available for preclinical research and their applications in biomedical and translational studies at the Crump Institute and at UCLA. He will be followed by Dr. Nick Bernthal, Chief, Division of Musculoskeletal Oncology and Director, UCLA Global Orthopaedic Initiative, who will present collaborative work between groups at UCLA, Johns Hopkins, and USC who developed and examined a preclinical model of posterior-approach spinal surgery. Employing several imaging modalities, these studies demonstrate a successful model for noninvasive, in vivo examination of spine implant infection where both bacterial burden and host inflammation can be monitored longitudinally in real-time without requiring animal sacrifice.
 
Join us to learn how successful research institutions are using in vivo imaging to aid their ongoing preclinical and translational research programs.  Doctors Lee and Bernthal will be happy to answer your questions following the presentation.